Learn more

GENESIS RES & DEV CORP LTD

Overview
  • Total Patents
    266
About

GENESIS RES & DEV CORP LTD has a total of 266 patent applications. Its first patent ever was published in 1996. It filed its patents most often in United States, New Zealand and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are MOGAM BIOTECH RES INST, ONYX PHARMA INC and MACFARLANE BURNET CT FOR MEDIC.

Patent filings per year

Chart showing GENESIS RES & DEV CORP LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Glenn Matthew 45
#2 Watson James D 38
#3 Sleeman Matthew 28
#4 Prestidge Ross L 26
#5 Bloksberg Leonard Nathan 25
#6 Havukkala Ilkka Jaakko 22
#7 Lasham Annette 22
#8 Strachan Lorna 21
#9 Tan Paul 21
#10 Visser Elizabeth S 21

Latest patents

Publication Filing date Title
WO2010027279A2 Compositions and methods for the treatment and prevention of neoplastic disorders
WO2008026946A2 Compositions and methods for the treatment and prevention of neoplastic disorders
NZ554249A I-SST enzyme isolated from forage grasses and methods for its use
NZ554250A Isolated terminal flower 1 gene (TFL1) from festuca arundinacea and methods for its use
US2007110752A1 Fibroblast growth factor receptors and methods for their use
US2007004666A1 Methods for modulating apoptotic cell death
AU2005209642A1 Compositions affecting programmed cell death and their use in the modification of forestry plant development
US2006115483A1 Fibroblast growth factor receptors and methods for their use
EP1716164A1 Targeted delivery of rna interference molecules for the treatment of ige-mediated disorders
US2005112642A1 Fibroblast growth factor receptors and methods for their use
US2005009750A1 Fibroblast growth factor receptors and methods for their use
AU2004202771A1 Materials and methods for the modification of plant cell wall polysaccharides
US2004247622A1 Methods and compounds for the treatment of immunologically-mediated diseases using Mycobacterium vaccae
EP1711609A1 Polynucleotides and polypeptides isolated from lactobacillus rhamnosus hn001 materials incorporating them and methods for using them
CA2501958A1 Polynucleotides and polypeptides derived from lactobacillus rhamnosus hn001
NZ538532A Polypeptides involved in the regulation of flowering in forage grasses
US2004058849A1 Methods for enhancing immune responses by fibroblast growth factor receptor 5 polypeptides
US2004072224A1 Compounds for treatment of infectious and immune system disorders and methods for their use
NZ582316A Sucrose phosphate synthases (SPS) from Lolium perenne and Festuca arundinacea
AU2003203517B2 Materials and methods for the modification of plant lignin content